Medical News

RSS

Stable asthma prevalence masks increase in allergic phenotype

The prevalence of childhood asthma in Sweden appears to have stabilised, with no increase seen between 1996 and 2006, researchers report.

25 Nov 2014

Philips' IQon Spectral CT receives FDA clearance

Reinforcing its commitment to enabling confident diagnosis through innovation, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IQon Spectral CT, presenting an entirely new approach to spectral imaging.

From Philips Healthcare 25 Nov 2014

Research sheds light on gene mutation linked to autistic traits

Researchers at the University of Leeds have shed light on a gene mutation linked to autistic traits.

25 Nov 2014

Jhpiego, SAGO partner to expand Ebola preparedness training across West Africa

Jhpiego is partnering with the Society of African Gynecologists and Obstetricians to expand and reinforce Ebola preparedness training for frontline health workers across West Africa in the event the virus outbreak spreads further in the region.

25 Nov 2014

New Drexel study sheds light on the role of socioeconomic environment on diabetes risk

As the linked epidemics of obesity and diabetes continue to escalate, a staggering one in five U.S. adults is projected to have diabetes by 2050.

25 Nov 2014

Researchers discover two common genetic variants associated with memory performance

In the largest study of the genetics of memory ever undertaken, an international researcher team including scientists from Boston University School of Medicine, have discovered two common genetic variants that are believed to be associated with memory performance.

25 Nov 2014

Long-term T therapy in hypogonadal men is safe, does not increase PCa risk, study finds

Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data.

25 Nov 2014

South Africa's response to Ebola outbreak

Brand South Africa and the Department of Communications yesterday convened a high level discussion with stakeholders on how the country is responding to the Ebola outbreak in West Africa.

25 Nov 2014

Lewy body dementia: 10 things people need to know

The recent news that the brain of actor/comedian Robin Williams showed signs of diffuse Lewy body disease has created more interest and coverage in this widely under-diagnosed condition than ever before.

25 Nov 2014

Four Pennsylvania businesses named recipients of 2014 Capital BlueCross Worksite Wellness Award

Capital BlueCross will recognize four Pennsylvania businesses with awards for excellence in worksite wellness during a ceremony on Dec. 9 from 9-11 a.m. at the Country Club of Harrisburg.

25 Nov 2014

Centinel Spine releases next generation Lumbar Integrated Interbody fusion device

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile fusion devices, introduced MIDLINE II, its next generation STALIF Family Lumbar Integrated Interbody fusion device.

25 Nov 2014

LaVision BioTec report on Dr Friedl’s research and his imaging of cancer growth

LaVision BioTec, developers of advanced microscopy solutions for the life sciences, report on the research of Dr Peter Friedl and his imaging of cancer growth using intravital microscopy.

25 Nov 2014

Choosing the best way to verify the quality and quantity of Chromatin Immunoprecipitation DNA

Porvair Sciences has published a new guide to help laboratories choose the best way to verify the quality and quantity of their Chromatin Immunoprecipitation (ChIP) DNA.

From Chromatrap® - Porvair Sciences Ltd 25 Nov 2014

PPMD, Santhera Pharmaceuticals collaborate to study Duchenne muscular dystrophy

Parent Project Muscular Dystrophy, the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne) and Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases, will collaborate on a benefit/risk study in Duchenne.

25 Nov 2014

Isis Pharmaceuticals announces initiation of ISIS-SMN Rx Phase 3 study in children with SMA

Isis Pharmaceuticals, Inc. announced today the initiation of a pivotal Phase 3 study evaluating ISIS-SMNRx in approximately 120 non-ambulatory children with spinal muscular atrophy (SMA).

25 Nov 2014

InSightec's MRgFUS system approved in Japan for treatment of women with uterine fibroids

Elbit Imaging Ltd. announced today that it was informed by InSightec Ltd. that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved InSightec's MR-guided Focused Ultrasound (MRgFUS) system for the treatment of pain palliation caused by bone metastases and advanced treatment for women with uterine fibroids.

25 Nov 2014

Eastern Europe restructures growth strategies to focus on medical devices sector

Governments in Eastern Europe have been forced to restructure their growth strategies and focus on attracting investors outside of the European Union in response to the Eurozone crisis.

25 Nov 2014

Gamma Medica, Volpara Solutions partner to improve breast cancer screening

Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman’s breast density and individual risk factors.

25 Nov 2014

Gamma Medica to offer Philips MicroDose SI as complement to LumaGEM MBI system

Gamma Medica today announces the company will now offer Philips MicroDose SI, the first full-field digital mammography (FFDM) system that supports single-shot, non-invasive spectral imaging, as a complement to its market leading LumaGEM Molecular Breast Imaging (MBI) system.

25 Nov 2014

Scientists identify potential weakness in cancer's ability to become resistant to treatment

Scientists at the University of Manchester have discovered a potential weakness in cancer's ability to return or become resistant to treatment, by targeting the 'fuel' part of stem cells which allows tumours to grow.

25 Nov 2014

Medical News

Stable asthma prevalence masks increase in allergic phenotype

Philips' IQon Spectral CT receives FDA clearance

Research sheds light on gene mutation linked to autistic traits

Jhpiego, SAGO partner to expand Ebola preparedness training across West Africa

New Drexel study sheds light on the role of socioeconomic environment on diabetes risk

Researchers discover two common genetic variants associated with memory performance

Long-term T therapy in hypogonadal men is safe, does not increase PCa risk, study finds

South Africa's response to Ebola outbreak

Lewy body dementia: 10 things people need to know

Four Pennsylvania businesses named recipients of 2014 Capital BlueCross Worksite Wellness Award

Centinel Spine releases next generation Lumbar Integrated Interbody fusion device

LaVision BioTec report on Dr Friedl’s research and his imaging of cancer growth

Choosing the best way to verify the quality and quantity of Chromatin Immunoprecipitation DNA

PPMD, Santhera Pharmaceuticals collaborate to study Duchenne muscular dystrophy

Isis Pharmaceuticals announces initiation of ISIS-SMN Rx Phase 3 study in children with SMA

InSightec's MRgFUS system approved in Japan for treatment of women with uterine fibroids

Eastern Europe restructures growth strategies to focus on medical devices sector

Gamma Medica, Volpara Solutions partner to improve breast cancer screening

Gamma Medica to offer Philips MicroDose SI as complement to LumaGEM MBI system

Scientists identify potential weakness in cancer's ability to become resistant to treatment

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Membrane proteins in focus: Turning high-risk targets into routine workflows

Latest News